Primary Tumour Response In Patients Treated With Nivolumab For Metastatic Renal Cell Carcinoma (Mrcc): Results Of The Getug-Afu 26 Nivoren TrialJ. Courcier,C. Dalban,B. Laguerre,S. Ladoire,P. Barthelemy,S. Oudard,F. Joly,G. Gravis Mescam,C. M. Chevreau,L. Geoffrois,E. Deluche,F. Rolland,D. Topart,S. Culine,S. Negrier,H. Mahammedi, F. Tantot,B. Escudier,R. Flippot,L. AlbigesAnnals of Oncology(2020)引用 1|浏览35暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要